Gout's progression from acute to chronic stages necessitates early diagnosis and adherence to treatment to prevent severe outcomes and reduce costs. Hyperuricemia is a primary factor in gout ...

A research team at the University of Virginia Hospital System found that a regularly-used medication for gout, called colchicine, helped improve the survival rates of hospitalized heart failure ...

A major international study has found gout is a chronic illness where genetics is a major cause, rather than lifestyle choices of the sufferer. Led by University of Otago researchers, the genome-wide ...

US-based biotechnology company Arthrosi Therapeutics has completed a series E funding round, amassing $153m which is earmarked to advance the clinical development of its flagship programme, ...

In a recent study published in the journal Nutrients, researchers investigated the causal association between gut microbiome (GM) composition, gout, and serological urate (SUA) values using Mendelian ...

Lingdolinurad lowers the incidence of acute gout flares in phase 2b studies—an advantage that remains challenging for existing gout therapies.

SEOUL, South Korea & CAMBRIDGE, Mass.--(BUSINESS WIRE)--LG Chem recently announced that the Company has submitted an IND application to the US FDA for its first independent global Phase 3 clinical ...

JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience, a clinical stage biotechnology company developing new treatments for inflammatory and metabolic diseases, announced today it will update its clinical ...

Although these lesions are typically a late feature of gout, gouty tophi occasionally present early in the course of disease, either as the initial manifestation of gout or within a few years of first ...

Background Although typically a late feature of gout, tophi may present early in the course of disease. The aim of this study was to identify factors associated with the presence of early tophaceous ...